Arctic Bioscience Investor Relations Material
Latest events
Q4 2023
Arctic Bioscience
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Arctic Bioscience
Access all reports
Arctic Bioscience AS is a biotechnology company that develops, manufactures and commercializes pharmaceutical products in Norway. Arctic Bioscience's proprietary technology platform includes a unique lipid-based adjuvant based on Algal oil derived from microalgae, carbon dioxide fixing organisms and proprietary delivery systems for use in combination with generic vaccine antigens. Arctic Bioscience AS was incorporated in 2011 and is based in Ørsta, Norway.
Key slides for Arctic Bioscience
Q2 2023
Arctic Bioscience
Q4 2023
Arctic Bioscience
Latest articles
Companies That Had Their IPO in 2023: Cautious Optimism
The cautiously optimistic market in 2023 saw stocks rebounded upwards, and interest in IPOs picked up from the previous year.
15 Apr 2024
Puig's 2024 IPO: Paco Rabanne, Jean Paul Gaultier, and Beyond
Explore Puig's journey from its 1914 inception to a 2024 IPO, showcasing its growth, strategic acquisitions, and impact in the beauty and fashion industry.
15 Apr 2024
Alphabet's Unstoppable Rise: From Stanford to Global Tech Leader
Discover Alphabet's rise from a university project to a global tech leader, highlighting its growth, diversification, and visionary leadership.
15 Apr 2024
Ticker symbol
Country
🇳🇴 Norway